Massive vaccine trial aims to stop debilitating chikungunya virus
NCT ID NCT07467707
First seen Jun 27, 2026 · Last updated Jun 30, 2026 · Updated 2 times
Summary
This study tests a new vaccine to prevent chikungunya, a virus that causes fever and severe joint pain. About 6,144 people aged 12 and older will receive either the vaccine or a placebo. Researchers will check if the vaccine safely prevents infection and reduces long-term joint problems.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHIKUNGUNYA VIRUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Kamphaeng Phet Provincial Hospital
RECRUITINGKamphaeng Phet, Changwat Kamphaeng Phet, 62000, Thailand
-
Songklanagarind hospital, Prince of Songkla University (PSU)
NOT_YET_RECRUITINGHat Yai, Changwat Songkhla, 90110, Thailand
-
WRAIR-AFRIMS Philippines, Cebu (WRAIR-APC)
RECRUITINGCebu City, Cebu, 6000, Philippines
More trials for these conditions
Other studies related to the condition(s) this trial covers.